Skip to main content
SpringerLink
Log in

The Liver and Immune Tolerance

  • Chapter
  • First Online:
Liver Immunology

Abstract

As the largest solid organ in the body, the liver plays a critical role in metabolism and detoxification. Recently, emerging evidence suggests that the liver is an immunological organ with unique properties of predominant innate immunity and immune tolerance. The characteristics of liver immune tolerance are associated with the unique anatomy, blood supply, the cell composition, as well as the microenvironment of this organ. The immune tolerance and predominance in innate immunity of liver are not only related to the pathogenesis of many liver diseases such as persistent hepatotropic viral infection and hepatic carcinoma, as well as the liver transplantation tolerance, but also affect the development of systemic diseases. Fully understanding the cellular and molecular mechanisms of the predominance of innate immunity, the formation of liver immune tolerance, as well as the subsequent induction of systemic tolerance, will provide foundation for development of novel therapeutic strategies for related diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wrenshall LE, Ansite JD, Eckman PM, Heilman MJ, Stevens RB, Sutherland DE. Modulation of immune responses after portal venous injection of antigen. Transplantation. 2001;71:841–50.

    Article  PubMed  CAS  Google Scholar 

  2. Benson JM, Stuckman SS, Cox KL, Wardrop RM, Gienapp IE, Cross AH, Trotter JL, et al. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol. 1999;162:6247–54.

    PubMed  CAS  Google Scholar 

  3. Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, et al. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am J Gastroenterol. 2000;95:966–73.

    Article  PubMed  CAS  Google Scholar 

  4. Yoshimura N, Matsui S, Hamashima T, Lee CJ, Ohsaka Y, Oka T. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum. Transplantation. 1990;49:167–71.

    Article  PubMed  CAS  Google Scholar 

  5. Morita H, Sugiura K, Inaba M, Jin T, Ishikawa J, Lian Z, Adachi Y, et al. A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci U S A. 1998;95:6947–52.

    Article  PubMed  CAS  Google Scholar 

  6. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, et al. Induction of immunological tolerance by porcine liver allografts. Nature. 1969;223:472–6.

    Article  PubMed  CAS  Google Scholar 

  7. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994;19:916–24.

    Article  PubMed  CAS  Google Scholar 

  8. Tiegs G, Lohse AW. Immune tolerance: what is unique about the liver. J Autoimmun. 2010;34:1–6.

    Article  PubMed  CAS  Google Scholar 

  9. Wang C, Sun J, Li L, Wang L, Dolan P, Sheil AG. Conversion of pancreas allograft rejection to acceptance by liver transplantation. Transplantation. 1998;65:188–92.

    Article  PubMed  CAS  Google Scholar 

  10. Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature. 1981;292:840–2.

    Article  PubMed  CAS  Google Scholar 

  11. Bumgardner GL, Heininger M, Li J, Xia D, Parker-Thornburg J, Ferguson RM, Orosz CG. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation. 1998;65:53–61.

    Article  PubMed  CAS  Google Scholar 

  12. Nagler A, Pines M, Abadi U, Pappo O, Zeira M, Rabbani E, Engelhardt D, et al. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. Hepatology. 2000;31:641–8.

    Article  PubMed  CAS  Google Scholar 

  13. Ilan Y, Margalit M, Ohana M, Gotsman I, Rabbani E, Engelhardt D, Nagler A. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. Hum Immunol. 2005;66:231–40.

    Article  PubMed  CAS  Google Scholar 

  14. Crispe IN. Liver antigen-presenting cells. J Hepatol. 2011;54:357–65.

    Article  PubMed  CAS  Google Scholar 

  15. Chen CH, Shu KH, Su YH, Tang KY, Cheng CH, Wu MJ, Yu TM, et al. Cotransplantation of hepatic stellate cells attenuates the severity of graft-versus-host disease. Transplant Proc. 2010;42:971–5.

    Article  PubMed  Google Scholar 

  16. Cao O, Dobrzynski E, Wang L, Nayak S, Mingle B, Terhorst C, Herzog RW. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood. 2007;110:1132–40.

    Article  PubMed  CAS  Google Scholar 

  17. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, et al. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Med. 2006;12:342–7.

    Article  PubMed  CAS  Google Scholar 

  18. Miao CH, Harmeling BR, Ziegler SF, Yen BC, Torgerson T, Chen L, Yau RJ, et al. CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood. 2009;114:4034–44.

    Article  PubMed  CAS  Google Scholar 

  19. LoDuca PA, Hoffman BE, Herzog RW. Hepatic gene transfer as a means of tolerance induction to transgene products. Curr Gene Ther. 2009;9:104–14.

    Article  PubMed  CAS  Google Scholar 

  20. Luth S, Huber S, Schramm C, Buch T, Zander S, Stadelmann C, Bruck W, et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest. 2008;118:3403–10.

    PubMed  Google Scholar 

  21. Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol. 2010;11:21–7.

    Article  PubMed  CAS  Google Scholar 

  22. Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology. 2008;47:729–36.

    Article  PubMed  CAS  Google Scholar 

  23. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147–63.

    Article  PubMed  CAS  Google Scholar 

  24. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev. 2000;174:47–62.

    Article  PubMed  CAS  Google Scholar 

  25. Bertolino P, Bowen DG, Benseler V. T cells in the liver: there is life beyond the graveyard. Hepatology. 2007;45:1580–2.

    Article  PubMed  Google Scholar 

  26. Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492–9.

    Article  PubMed  CAS  Google Scholar 

  27. Yi JS, Cox MA, Zajac AJ. T-cell exhaustion: characteristics, causes and conversion. Immunology. 2010;129:474–81.

    Article  PubMed  CAS  Google Scholar 

  28. Maini MK, Schurich A. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J Hepatol. 2010;52:616–9.

    Article  PubMed  CAS  Google Scholar 

  29. Watanabe T, Bertoletti A, Tanoto TA. PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. J Viral Hepat. 2010;17:453–8.

    Article  PubMed  CAS  Google Scholar 

  30. Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. 2010;10:753–66.

    Article  PubMed  CAS  Google Scholar 

  31. Holz LE, Benseler V, Vo M, McGuffog C, Van Rooijen N, McCaughan GW, Bowen DG, et al. Naive CD8 T cell activation by liver bone marrow-derived cells leads to a “neglected” IL-2low Bimhigh phenotype, poor CTL function and cell death. J Hepatol. 2012;57:830–6.

    Article  PubMed  CAS  Google Scholar 

  32. Knolle PA. The liver’s imprint on CD8(+) T cell priming. J Hepatol. 2012;57:718–9.

    Article  PubMed  Google Scholar 

  33. Carambia A, Herkel J. CD4 T cells in hepatic immune tolerance. J Autoimmun. 2010;34:23–8.

    Article  PubMed  CAS  Google Scholar 

  34. Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol Rev. 2006;213:101–18.

    Article  PubMed  Google Scholar 

  35. Bottcher JP, Knolle PA, Stabenow D. Mechanisms balancing tolerance and immunity in the liver. Dig Dis. 2011;29:384–90.

    PubMed  Google Scholar 

  36. Carambia A, Frenzel C, Bruns OT, Schwinge D, Reimer R, Hohenberg H, Huber S, et al. Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells. J Hepatol. 2013;58(1):112–8.

    Article  PubMed  CAS  Google Scholar 

  37. Kruse N, Neumann K, Schrage A, Derkow K, Schott E, Erben U, Kuhl A, et al. Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3-regulatory T cells suppressing autoimmune hepatitis. Hepatology. 2009;50:1904–13.

    Article  PubMed  CAS  Google Scholar 

  38. Schurich A, Bottcher JP, Burgdorf S, Penzler P, Hegenbarth S, Kern M, Dolf A, et al. Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells. Hepatology. 2009;50:909–19.

    Article  PubMed  CAS  Google Scholar 

  39. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, Momburg F, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med. 2000;6:1348–54.

    Article  PubMed  CAS  Google Scholar 

  40. Ebrahimkhani MR, Mohar I, Crispe IN. Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology. 2011;54:1379–87.

    Article  PubMed  CAS  Google Scholar 

  41. Schildberg FA, Hegenbarth SI, Schumak B, Scholz K, Limmer A, Knolle PA. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol. 2008;38:957–67.

    Article  PubMed  CAS  Google Scholar 

  42. Kern M, Popov A, Scholz K, Schumak B, Djandji D, Limmer A, Eggle D, et al. Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology. 2010;138:336–46.

    Article  PubMed  CAS  Google Scholar 

  43. You Q, Cheng L, Kedl RM, Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. 2008;48:978–90.

    Article  PubMed  CAS  Google Scholar 

  44. Breous E, Somanathan S, Vandenberghe LH, Wilson JM. Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology. 2009;50:612–21.

    Article  PubMed  CAS  Google Scholar 

  45. Kuniyasu Y, Marfani SM, Inayat IB, Sheikh SZ, Mehal WZ. Kupffer cells required for high affinity peptide-induced deletion, not retention, of activated CD8+ T cells by mouse liver. Hepatology. 2004;39:1017–27.

    Article  PubMed  Google Scholar 

  46. Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-beta. Hepatology. 2011;53:306–16.

    Article  PubMed  CAS  Google Scholar 

  47. Beattie L, Peltan A, Maroof A, Kirby A, Brown N, Coles M, Smith DF, et al. Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells. PLoS Pathog. 2010;6:e1000805.

    Article  PubMed  Google Scholar 

  48. Wiegard C, Wolint P, Frenzel C, Cheruti U, Schmitt E, Oxenius A, Lohse AW, et al. Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance. Gastroenterology. 2007;133:2010–8.

    Article  PubMed  CAS  Google Scholar 

  49. Holz LE, Benseler V, Bowen DG, Bouillet P, Strasser A, O’Reilly L, d’Avigdor WM, et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology. 2008;135:989–97.

    Article  PubMed  Google Scholar 

  50. Wahl C, Bochtler P, Schirmbeck R, Reimann J. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes. J Immunol. 2007;178:2083–93.

    PubMed  CAS  Google Scholar 

  51. Muhlbauer M, Fleck M, Schutz C, Weiss T, Froh M, Blank C, Scholmerich J, et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol. 2006;45:520–8.

    Article  PubMed  Google Scholar 

  52. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity. 2007;26:117–29.

    Article  PubMed  CAS  Google Scholar 

  53. Yang HR, Hsieh CC, Wang L, Fung JJ, Lu L, Qian S. A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery. 2010;30:332–7.

    Article  PubMed  Google Scholar 

  54. Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, et al. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011;53:1007–19.

    Article  PubMed  CAS  Google Scholar 

  55. Chou HS, Hsieh CC, Charles R, Wang L, Wagner T, Fung JJ, Qian S, et al. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation. 2012;93:272–82.

    Article  PubMed  CAS  Google Scholar 

  56. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, Gonen M, et al. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol. 2009;182:1901–11.

    Article  PubMed  CAS  Google Scholar 

  57. Xia S, Guo Z, Xu X, Yi H, Wang Q, Cao X. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood. 2008;112:3175–85.

    Article  PubMed  CAS  Google Scholar 

  58. Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, Curti A, Danese S, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood. 2006;108:218–27.

    Article  PubMed  CAS  Google Scholar 

  59. Castellaneta A, Sumpter TL, Chen L, Tokita D, Thomson AW. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol. 2009;183:6922–32.

    Article  PubMed  CAS  Google Scholar 

  60. Matta BM, Raimondi G, Rosborough BR, Sumpter TL, Thomson AW. IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. J Immunol. 2012;188:5227–37.

    Article  PubMed  CAS  Google Scholar 

  61. Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, Asselin-Paturel C, Trinchieri G, et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity. 2008;29:464–75.

    Article  PubMed  CAS  Google Scholar 

  62. Lunz III JG, Specht SM, Murase N, Isse K, Demetris AJ. Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology. 2007;46:1946–59.

    Article  PubMed  CAS  Google Scholar 

  63. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev. 2008;222:162–79.

    Article  PubMed  CAS  Google Scholar 

  64. Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 2008;68:2561–3.

    Article  PubMed  CAS  Google Scholar 

  65. Chan T, Wiltrout RH, Weiss JM. Immunotherapeutic modulation of the suppressive liver and tumor microenvironments. Int Immunopharmacol. 2011;11:879–89.

    Article  PubMed  CAS  Google Scholar 

  66. Ilkovitch D, Lopez DM. The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res. 2009;69:5514–21.

    Article  PubMed  CAS  Google Scholar 

  67. Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology. 2009;50:799–807.

    Article  PubMed  CAS  Google Scholar 

  68. Li H, Han Y, Guo Q, Zhang M, Cao X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol. 2009;182:240–9.

    PubMed  CAS  Google Scholar 

  69. Chen S, Akbar SM, Abe M, Hiasa Y, Onji M. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol. 2011;166:134–42.

    Article  PubMed  CAS  Google Scholar 

  70. Wang Y, Gu X, Xiang J, Chen Z. Myeloid-derived suppressor cells participate in preventing graft rejection. Clin Dev Immunol. 2012;2012:731486.

    PubMed  Google Scholar 

  71. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, Dustin ML, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 2005;3:e113.

    Article  PubMed  Google Scholar 

  72. Margalit M, Ilan Y. Induction of immune tolerance: a role for natural killer T lymphocytes? Liver Int. 2005;25:501–4.

    Article  PubMed  Google Scholar 

  73. Liu Y, Luan X, Li J, He Y, Li M. The role of invariant NKT cells in liver transplant tolerance in rats. Transplant Proc. 2012;44:1041–4.

    Article  PubMed  CAS  Google Scholar 

  74. Zhao N, Hao J, Ni Y, Luo W, Liang R, Cao G, Zhao Y, et al. Vgamma4 gammadelta T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol. 2011;187:5007–14.

    Article  PubMed  CAS  Google Scholar 

  75. Rhodes KA, Andrew EM, Newton DJ, Tramonti D, Carding SR. A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. Eur J Immunol. 2008;38:2274–83.

    Article  PubMed  CAS  Google Scholar 

  76. Malone F, Carper K, Reyes J, Li W. gammadeltaT cells are involved in liver transplant tolerance. Transplant Proc. 2009;41:233–5.

    Article  PubMed  CAS  Google Scholar 

  77. Wu X, Chen Y, Wei H, Sun R, Tian Z. Development of murine hepatic NK cells during ontogeny: comparison with spleen NK cells. Clin Dev Immunol. 2012;2012:759765.

    PubMed  Google Scholar 

  78. Wu X, Chen Y, Sun R, Wei H, Tian Z. Impairment of hepatic NK cell development in IFN-gamma deficient mice. Cytokine. 2012;60:616–25.

    Article  PubMed  CAS  Google Scholar 

  79. Yoshida O, Akbar SM, Chen S, Miyake T, Abe M, Murakami H, Hiasa Y, et al. Regulatory natural killer cells in murine liver and their immunosuppressive capacity. Liver Int. 2010;30:906–12.

    Article  PubMed  CAS  Google Scholar 

  80. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat. 2005;12:38–45.

    Article  PubMed  CAS  Google Scholar 

  81. Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol. 2012;12:201–13.

    Article  PubMed  CAS  Google Scholar 

  82. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol. 2011;54:209–18.

    Article  PubMed  CAS  Google Scholar 

  83. Li F, Wei H, Gao Y, Xu L, Yin W, Sun R, Tian Z. Blocking the natural killer (NK) cell inhibitory receptor NKG2A increases activity of human NK cells and clears HBV infection in mice. Gastroenterology. 2013;144(2):392–401.

    Article  PubMed  CAS  Google Scholar 

  84. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H. TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012;8:e1002594.

    Article  PubMed  CAS  Google Scholar 

  85. Moritoki Y, Zhang W, Tsuneyama K, Yoshida K, Wakabayashi K, Yang GX, Bowlus C, et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology. 2009;136:1037–47.

    Article  PubMed  CAS  Google Scholar 

  86. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000;12:597–605.

    Article  PubMed  CAS  Google Scholar 

  87. Nakano T, Lai CY, Goto S, Hsu LW, Kawamoto S, Ono K, Chen KD, et al. Immunological and regenerative aspects of hepatic mast cells in liver allograft rejection and tolerance. PLoS One. 2012;7:e37202.

    Article  PubMed  CAS  Google Scholar 

  88. Knolle PA, Uhrig A, Hegenbarth S, Loser E, Schmitt E, Gerken G, Lohse AW. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol. 1998;114:427–33.

    Article  PubMed  CAS  Google Scholar 

  89. Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity. 2009;31:145–57.

    Article  PubMed  CAS  Google Scholar 

  90. Meyaard L, Hurenkamp J, Clevers H, Lanier LL, Phillips JH. Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol. 1999;162:5800–4.

    PubMed  CAS  Google Scholar 

  91. Jansen CA, Cruijsen CW, de Ruiter T, Nanlohy N, Willems N, Janssens-Korpela PL, Meyaard L. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol. 2007;37:914–24.

    Article  PubMed  CAS  Google Scholar 

  92. Metzger TC, Anderson MS. Control of central and peripheral tolerance by AIRE. Immunol Rev. 2011;241:89–103.

    Article  PubMed  CAS  Google Scholar 

  93. Poliani PL, Kisand K, Marrella V, Ravanini M, Notarangelo LD, Villa A, Peterson P, et al. Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. Am J Pathol. 2010;176:1104–12.

    Article  PubMed  CAS  Google Scholar 

  94. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med. 1996;2:198–203.

    Article  PubMed  CAS  Google Scholar 

  95. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, O’Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology. 1999;29:1193–8.

    Article  PubMed  CAS  Google Scholar 

  96. Jaleco AC, Blom B, Res P, Weijer K, Lanier LL, Phillips JH, Spits H. Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells. J Immunol. 1997;159:694–702.

    PubMed  CAS  Google Scholar 

  97. Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology. 2010;138:682–93, 693e681–4.

    Google Scholar 

  98. Tzeng HT, Tsai HF, Liao HJ, Lin YJ, Chen L, Chen PJ, Hsu PN. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One. 2012;7:e39179.

    Article  PubMed  CAS  Google Scholar 

  99. Han Q, Zhang C, Zhang J, Tian Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology. 2011;54:1179–89.

    Article  PubMed  CAS  Google Scholar 

  100. Ebert G, Poeck H, Lucifora J, Baschuk N, Esser K, Esposito I, Hartmann G, et al. 5′ Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. Gastroenterology. 2011;141:696–706, 706e691–3.

    Google Scholar 

  101. Poeck H, Besch R, Maihoefer C, Renn M, Tormo D, Morskaya SS, Kirschnek S, et al. 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat Med. 2008;14:1256–63.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Immunopharmacology & Immunotherapy, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, 250012, China

    Zhigang Tian M.D., Ph.D. & Cai Zhang

  2. Department of Microbiology and Immunology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027, China

    Zhigang Tian M.D., Ph.D. & Zhe-Xiong Lian

Authors
  1. Zhigang Tian M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cai Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhe-Xiong Lian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhigang Tian M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Division of Rheumatology, Allergy and Clinical Immunology, University of California School of Medicine, Davis, California, USA

    M. Eric Gershwin

  2. Medicine and Surgery, Baylor College of Medicine, Houston, Texas, USA

    John M. Vierling

  3. Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Germany

    Michael P. Manns

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tian, Z., Zhang, C., Lian, ZX. (2014). The Liver and Immune Tolerance. In: Gershwin, M., Vierling, J., Manns, M. (eds) Liver Immunology. Springer, Cham. https://doi.org/10.1007/978-3-319-02096-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-02096-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-02095-2

  • Online ISBN: 978-3-319-02096-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation